Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

被引:401
作者
Assmann, G [1 ]
Schulte, H [1 ]
vonEckardstein, A [1 ]
机构
[1] UNIV MUNSTER, ZENT LAB, INST KLIN CHEM & LAB MED, W-4400 MUNSTER, GERMANY
关键词
D O I
10.1016/S0002-9149(96)00159-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular risk factors were analyzed in 4,849 male participants, aged 40 to 65 years, in an 8-year follow-vp of the Munster Heart Study (Prospective Cardiovascular Munster Study; PROCAM). One hundred eighty-one definite nonfatal myocardial infarctions, 49 fatal myocardial infarctions, and 28 sudden cardiac deaths were observed. Multiple logistic function analysis confirmed that age, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, cigarette smoking, diabetes mellitus, angina pectoris, and family history of myocardial infarction were important cardiovascular risk factors. Interestingly, this analysis revealed a significant and independent association between serum levels of triglycerides and the incidence of major coronary events. The relation between lipoprotein(a) [Lp(a)] levels and the occurrence of major coronary events was analyzed in a subgroup of 878 men. Thirty-three probands with major coronary events had significantly higher geometric mean levels of Lp(a) than 828 men who did not experience major coronary events (0.09 vs 0.05 g/L; p < 0.011). Thus, in addition to established risk factors, serum levels of triglycerides and Lp(a) are sensitive indicators of increased risk for major coronary events.
引用
收藏
页码:1179 / 1184
页数:6
相关论文
共 30 条
[1]   RELATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES TO INCIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE (THE PROCAM EXPERIENCE) [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (07) :733-737
[2]  
Assmann G, 1993, LIPID METABOLISM DIS, P19
[3]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[4]   RISK-FACTORS IN MIDDLE-AGE THAT PREDICT EARLY AND LATE ONSET OF CORONARY HEART-DISEASE [J].
BENFANTE, RJ ;
REED, DM ;
MACLEAN, CJ ;
YANO, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (02) :95-104
[5]  
CRAIG WY, 1992, CLIN CHEM, V38, P550
[6]   LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS) [J].
CREMER, P ;
NAGEL, D ;
LABROT, B ;
MANN, H ;
MUCHE, R ;
ELSTER, H ;
SEIDEL, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) :444-453
[7]   PLASMA TRIGLYCERIDE LEVEL AND MORTALITY FROM CORONARY HEART-DISEASE [J].
CRIQUI, MH ;
HEISS, G ;
COHN, R ;
COWAN, LD ;
SUCHINDRAN, CM ;
BANGDIWALA, S ;
KRITCHEVSKY, S ;
JACOBS, DR ;
OGRADY, HK ;
DAVIS, CE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) :1220-1225
[8]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[9]  
GOUGH SCL, 1993, CARDIOVASC RISK FACT, V3, P387
[10]  
Grainger David J., 1995, Current Opinion in Lipidology, V6, P81, DOI 10.1097/00041433-199504000-00004